Baxter International Inc stock (US0718131099): Shares drop 2.56% to $17.53

Baxter International Inc stock declined 2.56% on Monday, May 11, 2026, closing at $17.53 after opening at $17.99, according to data from StockInvest.us as of May 11, 2026. Trading volume reached significant levels during the session, reflecting investor reactions to recent market pressures in the healthcare sector.

As of: 12.05.2026

By the editorial team – specialized in equity coverage.

Baxter International Inc: core business model

Baxter International Inc develops, manufactures and markets products supporting healthcare professionals in hospitals and clinics worldwide. The company focuses on hospital products including IV therapies, infusion pumps, and renal care solutions. Its business spans acute and chronic care settings, serving patients through innovative medical devices and therapies.

Main revenue and product drivers for Baxter International Inc

Key revenue streams come from segments like Medical Products and Therapies, which include nutritionals, pharmacy compounding, and surgical equipment. Renal care remains a cornerstone, with products for dialysis treatments. In Q1 2026 data published earlier this year, the company reported ongoing demand in these areas amid US hospital spending trends, per its filings.

Conclusion

Baxter International Inc continues to navigate volatility in the medical device sector, with recent price action showing a 2.56% drop on May 11, 2026. US investors track its NYSE-listed shares for exposure to hospital supply chains. Market dynamics and volume suggest ongoing interest despite short-term pressures.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.